Joule Financial LLC Purchases New Shares in Kenvue Inc. (NYSE:KVUE)

Joule Financial LLC purchased a new position in Kenvue Inc. (NYSE:KVUE - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 24,474 shares of the company's stock, valued at approximately $523,000.

Other large investors have also made changes to their positions in the company. Mutual of America Capital Management LLC boosted its stake in Kenvue by 40.4% during the second quarter. Mutual of America Capital Management LLC now owns 317,504 shares of the company's stock worth $5,772,000 after buying an additional 91,398 shares during the period. XTX Topco Ltd purchased a new position in Kenvue during the 2nd quarter worth approximately $746,000. Intech Investment Management LLC increased its stake in Kenvue by 48.2% in the second quarter. Intech Investment Management LLC now owns 564,279 shares of the company's stock valued at $10,259,000 after purchasing an additional 183,451 shares during the period. Benjamin F. Edwards & Company Inc. raised its stake in shares of Kenvue by 4.7% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 43,744 shares of the company's stock worth $795,000 after purchasing an additional 1,971 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado boosted its holdings in Kenvue by 8.1% in the 2nd quarter. Public Employees Retirement Association of Colorado now owns 262,892 shares of the company's stock valued at $4,779,000 after purchasing an additional 19,591 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

KVUE has been the topic of a number of research analyst reports. UBS Group decreased their target price on Kenvue from $24.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday. Piper Sandler raised shares of Kenvue from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $21.00 to $26.00 in a research note on Monday, January 6th. Citigroup reduced their price target on shares of Kenvue from $25.00 to $21.00 and set a "neutral" rating on the stock in a research report on Wednesday. Barclays decreased their target price on shares of Kenvue from $23.00 to $21.00 and set an "equal weight" rating for the company in a research note on Friday. Finally, Deutsche Bank Aktiengesellschaft lowered Kenvue from a "buy" rating to a "hold" rating and lowered their price objective for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $23.08.

Kenvue Price Performance

Shares of NYSE:KVUE traded down $0.09 during midday trading on Friday, reaching $21.11. 11,266,973 shares of the company's stock were exchanged, compared to its average volume of 8,612,558. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The company's 50 day simple moving average is $22.42 and its two-hundred day simple moving average is $21.71. The firm has a market capitalization of $40.46 billion, a PE ratio of 38.37, a price-to-earnings-growth ratio of 1.99 and a beta of 1.46. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts' consensus estimates of $0.27 by $0.01. The company had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The firm's quarterly revenue was down .4% compared to the same quarter last year. During the same period last year, the company posted $0.31 earnings per share. Equities research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.89%. The ex-dividend date is Wednesday, February 12th. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.